1.Neonatal priapism associated with spontaneous bilateral pyocavernositis.
Rajeev SOOD ; Surender Nath WADHWA ; Vikas JAIN
Annals of the Academy of Medicine, Singapore 2006;35(6):425-427
INTRODUCTIONNeonatal priapism is known to be associated with a wide range of aetiologies, but an association with spontaneous purulent cavernositis has not been reported in the paediatric literature. We report the first of such case.
CLINICAL PICTUREA 24-day-old neonate was brought with the history of persistent erection of penis since day 4 of life and swollen penis of 4 days' duration, which revealed frank pus on cavernosal aspiration bilaterally.
TREATMENTThe child was treated with closed aspiration drainage; cross-irrigation with antibiotic solution under systemic antibiotic cover helped in achieving complete detumescence.
OUTCOMEOn follow-up, child demonstrated normal full bladder tumescence and colour doppler revealed bilateral normal corporo-cavernosal appearance and blood flow, indicating good functional and anatomical recovery.
CONCLUSIONThis case report describes the presentation, successful management and excellent functional and anatomical outcome, on follow-up, of this rare association of neonatal priapism with spontaneous bilateral pyocavernositis. An attempt has been made to describe the underlying pathophysiology.
Algorithms ; Humans ; Infant, Newborn ; Inflammation ; complications ; Male ; Penile Diseases ; complications ; Priapism ; complications ; therapy ; Suppuration
2.Colitis and Crohn’s Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease
Ajit SOOD ; Vineet AHUJA ; Vandana MIDHA ; Saroj Kant SINHA ; C. Ganesh PAI ; Saurabh KEDIA ; Varun MEHTA ; Sawan BOPANNA ; Philip ABRAHAM ; Rupa BANERJEE ; Shobna BHATIA ; Karmabir CHAKRAVARTTY ; Sunil DADHICH ; Devendra DESAI ; Manisha DWIVEDI ; Bhabhadev GOSWAMI ; Kirandeep KAUR ; Rajeev KHOSLA ; Ajay KUMAR ; Ramit MAHAJAN ; S. P. MISRA ; Kiran PEDDI ; Shivaram Prasad SINGH ; Arshdeep SINGH
Intestinal Research 2020;18(4):355-378
Despite several recent advances in therapy in inflammatory bowel disease (IBD), 5-aminosalicylic acid (5-ASA) therapy has retained its place especially in ulcerative colitis. This consensus on 5-ASA is obtained through a modified Delphi process, and includes guiding statements and recommendations based on literature evidence (randomized trials, and observational studies), clinical practice, and expert opinion on use of 5-ASA in IBD by Indian gastroenterologists. The aim is to aid practitioners in selecting appropriate treatment strategies and facilitate optimal use of 5-ASA in patients with IBD.